AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Find out what a market index is, its typical components, and how analysts and investors use it to gauge market health.
27,179 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A notable insider maneuver at CareDx drew attention to the stock. This article breaks down the sale, what it means fo...
A renewed policy debate on redistributing elon musk’s trillion raises questions about liquidity, feasibility, and the...
Pennymac confirms it will shutter its Franklin, TN office and reduce staff in its consumer direct lending unit, part ...
Bitcoin is pulling back from its peak, a move many investors fear. History, though, suggests cycles, patience, and di...
U.S. Q1 GDP was revised higher to a 2.1% annualized pace, topping prior estimates. The gain sparks relief in markets ...
As the CLARITY Act advances, these crypto tokens could see renewed investor interest. Grayscale highlights revenue-ge...
Investors are weighing XRP's future over a three-year horizon. This article lays out a realistic outlook, three scena...
Investors are watching canopy growth's medical marijuana as a potential engine for a rebound. This guide breaks down ...
AST SpaceMobile just completed a trio of successful BlueBird launches, yet spacemobile's stock down after the event. ...
Three legendary investors are loading up on a single AI stock that's trading at a discount to its long‑term value. Th...
Palantir surged about 9% after announcing a Sovereign-AI partnership with NVIDIA, aimed at secure, air-gapped governm...